Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial
- Resource Type
- Article
- Source
- In
American Journal of Transplantation June 2018 18(6):1424-1434 - Subject
- Language
- ISSN
- 1600-6135